521 results on '"Brockow K"'
Search Results
2. Flow‐based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper.
3. COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations
4. Increasing the COVID‐19 immunization rate through allergy testing.
5. Component Resolved Diagnosis in Hymenoptera Anaphylaxis
6. An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity
7. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
8. COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations
9. Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts
10. Impact of pollen associated lipid mediators (PALMs) from grass pollen on human mast cells [Abstract]
11. Added sensitivity of component-resolved diagnosis in hymenoptera venom-allergic patients with elevated serum tryptase and/or mastocytosis
12. Hydrolysed egg displays strong decrease in allergenicity and is well tolerated by egg-allergic patients
13. Genetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic review
14. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group
15. Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes?
16. Wheat-dependent exercise-induced anaphylaxis
17. Validation of dermatopathological criteria to diagnose cutaneous lesions of mastocytosis: importance of KIT D816V mutation analysis.
18. Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitis
19. Pathogenesis of drug allergy – current concepts and recent insights
20. Periorbital papules and erythematous-brownish plaques on the neck and axilla
21. Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper
22. The basophil activation test differentiates between patients with wheat-dependent exercise-induced anaphylaxis and control subjects using gluten and isolated gluten protein types
23. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
24. Management of anaphylaxis due to COVID-19 vaccines in the elderly
25. Radiotherapy with soft X-rays in Dupuytrenʼs disease – successful, well-tolerated and satisfying
26. Transplantation einer fixen Arzneireaktion – Einblicke in das residente Immunsystem der Haut: DK03/04
27. Klinischer Verlauf einer bullösen diffusen kutanen Mastozytose: DK02/03
28. Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis
29. Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis
30. Dilemmas of allergy diagnosis in perioperative anaphylaxis
31. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology
32. Global Allergy Forum and Second Davos Declaration 2013 Allergy: Barriers to cure – challenges and actions to be taken
33. Heterogeneity of molecular sensitization profiles in grass pollen allergy – implications for immunotherapy?
34. International Consensus on drug allergy
35. Advances in our understanding of drug hypersensitivity
36. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs
37. Desensitization in delayed drug hypersensitivity reactions – an EAACI position paper of the Drug Allergy Interest Group
38. Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper
39. Neue Soforttypallergene - Omega-5-Gliadin: S22/02
40. Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio-oedema
41. Time for more clinical research on non-steroidal anti-inflammatory drug-induced urticaria/angioedema and anaphylaxis
42. A shortened docetaxel desensitization protocol for use in special cases
43. Antihistaminika-Überempfindlichkeit bei chronischer Urtikaria?: DK02/05
44. A high-troughput screening assay for detection of auto-IgE: P009
45. Erythema scarlatiniforme desquamativum recidivans
46. Successful treatment with infliximab despite positive tuberculosis ELISpot results in a patient with pityriasis rubra pilaris taking prophylactic isoniazid
47. Can Immunoglobulin E-measurement replace challenge tests in allergic rhinoconjunctivits to grass pollen?
48. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA# and GA2LEN/HANNA*
49. Humane Seminalplasma-Allergie: Allergen-spezifische Immuntherapie mit Prostata-spezifischem Antigen (PSA): DK02/08
50. Systemtherapie bei Anaphylaxie - State of the Art: TF02/02
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.